<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><id>4619</id>
	<dc:title xml:lang="de-DE">Das Potenzial der mRNA-Technologie: Der Weg des Biotechnologieunternehmens CureVac</dc:title>
	<dc:title xml:lang="en-US">The potential of mRNA technology:  </dc:title>
	<dc:creator>Giesler, Simone</dc:creator>
	<dc:subject xml:lang="de-DE">mRNA</dc:subject>
	<dc:subject xml:lang="de-DE">COVID</dc:subject>
	<dc:subject xml:lang="de-DE">SARS</dc:subject>
	<dc:subject xml:lang="de-DE">Immunonkologie</dc:subject>
	<dc:subject xml:lang="de-DE">Impfstoffe</dc:subject>
	<dc:subject xml:lang="de-DE">Infektionskrankheiten</dc:subject>
	<dc:description xml:lang="de-DE">Die mRNA-Technologie lässt eine neue Produktklasse in der Medizin entstehen, mit der gegen Infektionserkrankungen prophylaktisch und gegen viele Krebsarten therapeutisch geimpft werden kann sowie seltene Krankheiten bekämpft werden können.</dc:description>
	<dc:description xml:lang="en-US">mRNA technology is giving rise to a novel class of medical products that can be used to prophylactically vaccinate against infectious diseases and therapeutically vaccinate against many types of cancer, as well as to combat rare diseases.</dc:description>
	<dc:publisher xml:lang="de-DE">VBIO - Verband Biologie, Biowissenschaften &amp; Biomedizin in Deutschland</dc:publisher>
	<dc:date>2021-08-09</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.biuz.de/index.php/biuz/article/view/4619</dc:identifier>
	<dc:identifier>10.11576/biuz-4619</dc:identifier>
	<dc:source xml:lang="de-DE">Biologie in unserer Zeit; Bd. 51 Nr. 3 (2021): Edmonds Urzeit; 246-253</dc:source>
	<dc:source xml:lang="en-US">Biologie in unserer Zeit; Vol. 51 No. 3 (2021): Edmonds Urzeit; 246-253</dc:source>
	<dc:source>1521-415X</dc:source>
	<dc:source>0045-205X</dc:source>
	<dc:language>deu</dc:language>
	<dc:relation>https://www.biuz.de/index.php/biuz/article/view/4619/4387</dc:relation>
	<dc:rights xml:lang="de-DE">Copyright (c) 2021 Simone Giesler</dc:rights>
	<dc:rights xml:lang="de-DE">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>